Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study
Published in: Lupus
Date of publication: November 16, 2016
Main subject: placebo, systemic lupus erythematosus, pharmacodynamics
Bibliographic databases:
Cites articles 20
- November 1, 2004
- February 28, 2011
- January 31, 2014
Date
Title
Article -